• About us
  • Our scope
  • Our team
  • Our supporters
  • Contacting us
  • Our newsletter
  • Reports
  • Brochures
  • Renal conferences
  • Related web sites
• Reviews
  • Renal reviews
  • Renal protocols
  • Renal titles
• Writing a review
  • Potential review titles
  • Review process
    • Overview
    • Developing a title
    • Developing a protocol
    • Developing a review
    • Updating a review
  • For authors
  • For referees
  • Becoming involved
  • Workshops
• Trials in nephrology
  • Ongoing trials
  • Published trials
• Diagnostic reviews
• Prospective trial registration
  • Search for a registered study
• What's new?
• Home

Cochrane Renal Protocols

The following renal protocols are 'works in progress' and are published in the Cochrane Library. A subscription may be required if you are accessing the full-text of the Cochrane Library from outside Australia.

The latest issue of the Cochrane Library is Issue 2 2009

• Adjunctive therapies for HIV-associated nephropathy
• Advanced glycation end product (AGE) inhibitors for preventing the progression of diabetic kidney disease
• Aldosterone antagonists for preventing the progression of chronic kidney disease
• Altered dietary salt intake for preventing and treating diabetic kidney disease/
• Amphotericin B deoxycholate versus liposomal amphotericin B: effects on kidney function
• Androgens for the anaemia of chronic kidney disease in adults
• Angiotensin converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1-3) non diabetic chronic kidney disease
• Antibiotics for asymptomatic bacteriuria in the elderly
• Antibiotics for preventing urinary tract infections in kidney transplant recipients/
• Antibiotics for treating uncomplicated urinary tract infection in children
• Antibody immunosuppression for pancreas and kidney pancreas transplant recipients
• Antihypertensive agents for dialysis patients/Kannaiyan S Rabindranath
• Antihypertensive agents for preventing the progression of diabetic kidney disease
• Antihypertensive agents for renal transplant recipients
• Antimicrobial agents for treating uncomplicated urinary tract infection in women
• Atrial natriuretic peptide for preventing and treating acute renal failure

• Bicarbonate versus lactate solutions for acute haemodialysis
• Bicarbonate versus lactate solutions for acute peritoneal dialysis
• Biocompatible dialysis fluids for peritoneal dialysis/Kathryn J Wiggins

• Calcineurin inhibitor withdrawal or tapering for kidney transplant recipients
• Calcium channel blockers for ureteral stones
• Cephalosporins for treating acute uncomplicated pyelonephritis in adults
• Chinese medicinal herbs for diabetic kidney disease
• Chinese medicinal herbs for urinary calculi
• Continuous renal replacement therapies for acute renal failure in critically ill patients
• Contrast agents for preventing contrast-induced nephropathy

• Dietary interventions for preventing complications in idiopathic hypercalciuria
• Donor organs preservation techniques for kidney transplantation

• Early referral to specialist nephrology services for preventing the progression to end-stage kidney disease
• Education programmes for people with diabetic kidney disease
• Endoscopic treatment with or without stenting for the management of ureteric calculi
• Exercise training for chronic kidney disease patients
• Extracorporeal shock wave lithotripsy (ESWL) for kidney stones

• Glycosaminoglycan for preventing and treating diabetic kidney disease
• Growth factors for chronic kidney disease in adults

• High-flux versus low-flux haemodialysis membranes for end-stage renal disease
• Human albumin for intradialytic hypotension in haemodialysis patients
• Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function/Allison B Dart

• Insulin-sensitising therapies for preventing the progression of diabetic kidney disease
• Intensive versus standard haemodialysis water treatment for preventing low grade mineral intoxication in chronic haemodialysed patients
• Interventions for covert bacteriuria in children
• Interventions for dialysis associated restless legs syndrome
• Interventions for dialysis patients with hepatitis C virus (HCV) infection
• Interventions for erythropoietin-resistant anaemia in dialysis patients
• Interventions for lowering plasma homocysteine levels in dialysis patients
• Interventions for preventing and treating renal disease in Henoch-Schönlein Purpura (HSP)
• Interventions for preventing clotting of extracorporeal circuits during continuous renal replacement therapy
• Interventions for preventing haemolytic uraemic syndrome/ thrombotic thrombocytopenic purpura
• Interventions for preventing infectious complications in haemodialysis patients with central venous lines
• Interventions for preventing thrombosis in adults and children with nephrotic syndrome
• Interventions for treating sexual dysfunction in patients with chronic kidney disease
• Isolation as a strategy for controlling the transmission of hepatitis C virus (HCV) infection in haemodialysis units

• Laparoscopic versus open nephrectomy for live kidney donors
• Lipid-lowering agents for nephrotic syndrome
• Long-term nutritional interventions for adult kidney transplant recipients
• Low molecular weight heparin for diabetic kidney disease

• Methods for collecting urine samples in adults and children with suspected urinary tract infection
• Mycophenolic acid versus azathioprine as primary immunosuppression for kidney transplant recipients

• Non-immunosuppressive treatment for IgA nephropathy
• Non-steroidal anti-inflammatory drugs (NSAIDS) and non-opioids for acute renal colic
• Nutritional supplements for acute renal failure

• Pentoxifylline for diabetic kidney disease
• Pharmacological interventions for preventing recurrent urinary stones in adults and children
• Pharmacological interventions for preventing contrast-induced nephropathy
• Phosphate binders for preventing and treating bone disease in chronic kidney disease patients
• Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients/
• Preoperative vascular access evaluation for haemodialysis patients
• Prostaglandin E1 for preventing the progression of diabetic kidney disease

• Recombinant human insulin-like growth factor I for acute kidney injury
• Renal replacement therapy for preventing contrast-induced nephropathy

• Steroid avoidance or withdrawal for pancreas and kidney transplant recipients/Julio Pascual

• Tacrolimus for simultaneous kidney-pancreas transplant recipients
• Teicoplanin versus vancomycin for proven or suspected infection
• Therapeutic interventions for membranoproliferative glomerulonephritis
• Thyroxine for acute kidney injury
• Tidal peritoneal dialysis for acute renal failure

• Ultrasound use for the placement of haemodialysis catheters/Emma C Vaux
• Vitamin D analogues for preventing and treating bone disease in chronic kidney disease

New & updated reviews in
Cochrane Library
Issue 2 April 2009

HMG CoA reductase inhibitors (statins) for kidney transplant recipients

HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis

Updated Review with changed conclusion
sHMG Co-A reductase inhibitors (statins) for dialysis patients

17th Cochrane Colloquium
Singapore
11-14 Oct 2009

Systematic Review Workshops

2 workshops are planned for 2009 in June & December
[Details]

Are you interested in writing a review?

Contact us for potential review titles!

Help us with our Renal Trials Register

Do you have conference proceedings [books or cd-roms] that you no longer need or could lend to us for hadsearching? If so, email Ruth Mitchell for details

Handsearching

Are you interested in helping us handsearch journals or conference proceedings. To find out more about our handsearching activities, email Ruth Mitchell